Open AccessA Phase 2a clinical trial of Molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus
Author(s) -
William A. Fischer,
Joseph J. Eron,
Wayne Holman,
Myron S. Cohen,
Lei Fang,
Laura J Szewczyk,
Timothy P. Sheahan,
Ralph S. Baric,
Katie R. Mollan,
Cameron R. Wolfe,
Elizabeth R Duke,
Masoud Azizad,
Katyna Borroto–Esoda,
David A. Wohl,
Robert W. Coombs,
Amy James Loftis,
Paul Alabanza,
Felicia Lipansky,
Wendy Painter
Publication year - 2021
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/dmx8-nb74
Subject(s) - covid-19 , virology , rna , virus , biology , medicine , infectious disease (medical specialty) , outbreak , genetics , disease , gene